The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis-Reference-Cited by-同舟云学术

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis

Published:2017-01-21 Issue:3 Volume:36 Page:677-682
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Alpizar-Rodriguez D,Brulhart Laure,Mueller Ruediger B.,Möller Burkhard,Dudler Jean,Ciurea Adrian,Walker Ulrich A.,Von Mühlenen Ines,Kyburz Diego,Zufferey Pascal,Mahler Michael,Bas Sylvette,Gascon Danielle,Lamacchia Céline,Roux-Lombard Pascale,Lauper Kim,Nissen Michael J.,Courvoisier Delphine S.,Gabay Cem,Finckh Axel

Funder

Fonds National Suisse de la Recherche Scientifique

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-017-3547-3.pdf

Reference22 articles.

1. Klareskog L, Gregersen PK, Huizinga TW (2010) Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann Rheum Dis 69(12):2062–2066

2. Gerlag DM, Raza K, van Baarsen LG et al (2012) EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 71(5):638–641

3. Kokkonen H, Mullazehi M, Berglin E et al (2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther. 13(1):R13